Article
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
eLife · 2020 · Yvette Robbins, author Sarah Greene, author Jay Friedman, author Paul E Clavijo, author Carter Van Waes, author Kellsye P Fabian, author Michelle R Padget, author Houssein Abdul Sater, author John H Lee, author Patrick Soon-Shiong, author James Gulley, author Jeffrey Schlom, author James W Hodge, author Clint T Allen, author ([email protected]) Satyajit Rath, senior_editor Satyajit Rath, editor
Key facts
| Title | Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells |
|---|---|
| First author | Yvette Robbins, author Sarah Greene, author Jay Friedman, author Paul E Clavijo, author Carter Van Waes, author Kellsye P Fabian, author Michelle R Padget, author Houssein Abdul Sater, author John H Lee, author Patrick Soon-Shiong, author James Gulley, author Jeffrey Schlom, author James W Hodge, author Clint T Allen, author ([email protected]) Satyajit Rath, senior_editor Satyajit Rath, editor |
| Journal | eLife |
| Published | Jul 7, 2020 |
| DOI | 10.7554/eLife.54854 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1